The ubiquitin-dependent proteolysis of mitotic cyclin B, which is catalyzed
by the anaphase-promoting complex/cyclosome (APC/C) and ubiquitin-conjugat
ing enzyme H10 (UbcH10), begins around the time of the metaphase-anaphase t
ransition and continues through G1 phase of the next cell cycle. We have us
ed cell-free systems from mammalian somatic tells collected at different ce
ll cycle stages (GO, G1, S, G2, and M) to investigate the regulated degrada
tion of four targets of the mitotic destruction machinery: cyclins A and B,
geminin H (an inhibitor of S phase identified in Xenopus), and Cut2p (an i
nhibitor of anaphase onset identified in fission yeast). All four are degra
ded by G1 extracts but not by extracts of S phase cells. Maintenance of des
truction during G1 requires the activity of a PP2A-like phosphatase. Destru
ction of each target is dependent on the presence of an N-terminal destruct
ion box motif, is accelerated by additional wild-type UbcH10 and is blocked
by dominant negative UbcH10. Destruction of each is terminated by a domina
nt activity that appears in nuclei near the start of S phase. Previous work
indicates that the APC/C-dependent destruction of anaphase inhibitors is a
ctivated after chromosome alignment at the metaphase plate. In support of t
his, we show that addition of dominant negative UbcH10 to GI extracts block
s destruction of the yeast anaphase inhibitor Cut2p in vitro, and injection
of dominant negative UbcH10 blocks anaphase onset in vivo. Finally, we rep
ort that injection of dominant negative Ubc3/Cdc34, whose role in G1-S cont
rol is well established and has been implicated in kinetochore function dur
ing mitosis in yeast, dramatically interferes with congression of chromosom
es to the metaphase plate. These results demonstrate that the regulated ubi
quitination and destruction of critical mitotic proteins is highly conserve
d from yeast to humans.